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Objective: Protein kinase-like endoplasmic reticulum kinase (PERK) and protein kinase
R (PKR) are implicated in endoplasmic reticulum stress-induced arthritis and pro-
inflammatory cytokine-mediated cartilage degradation in vitro, respectively.We determined
whether knockout of the cellular inhibitor of PERK and PKR, P58IPK causes joint degener-
ation in vivo and whether these molecules are activated in human osteoarthritis (OA).
Materials and Methods: Sections of knee joints from P58IPK-null and wild-type mice aged
12–13 and 23–25 months were stained with toluidine blue and scored for degeneration
using the osteoarthritis research society international (OARSI) system. Bone changes were
assessed by radiology and high-resolution micro-computed tomography of hind limbs.
Sections from the medial tibial plateaus of two human knees, removed in total knee
replacement surgery for OA, were immunolabelled for phosphorylated PERK and PKR
and P58IPK.
Results: Knockout mice exhibited narrower tibiae (p=0.0031) and smaller epiphyses in tib-
iae (p=0.0004) and femora (p=0.0214). Older knockout mice had reduced total volume
inside the femoral periosteal envelope (p=0.023), reduced tibial (p=0.03), and femoral
(p=0.0012) bone volumes (BV) and reduced femoral BV fraction (p=0.025). Compared
with wild-types, younger P58IPK-null mice had increased OARSI scores in medial femoral
condyles (p= 0.035). Thirty four percent of null mice displayed severe joint degenera-
tion with complete articular cartilage loss from the medial compartment and heterotopic
chondro-osseous tissue in the medial joint capsule. Phosphorylated PERK and PKR were
localized throughout human osteoarthritic tibial plateaus but, in particular, in areas exhibiting
the most degeneration. There was limited expression of P58IPK.
Conclusion: This study is the first to reveal a critical role for P58IPK in maintaining joint
integrity in vivo, implicating the PKR and PERK stress signaling pathways in bony changes
underlying the pathogenesis of joint degeneration.
Keywords: P58IPK, bone, articular cartilage, osteoarthritis, PERK, PKR
INTRODUCTION
Osteoarthritis (OA) is a disease of the synovial joint associated
with pathological changes in the bone and cartilage that cause pain
and disability. Abnormal mechanical load and obesity represent
Abbreviations: µCT, micro-computed tomography; BV, bone volume; BV/TV,
bone volume fraction; eIF2α, eukaryotic initiation factor 2 alpha; ER, endoplas-
mic reticulum; GLM ANOVA, general linear model analysis of variance; IFN,
interferon; LFC, lateral femoral condyle; LTP, lateral tibial plateau; MFC, medial
femoral condyle; MTP, medial tibial plateau; MV, marrow volume; OA, osteoarthri-
tis; OARSI, Osteoarthritis Research Society International; P58IPK, 58 kDa inhibitor
protein kinase; PERK, protein kinase-like endoplasmic reticulum kinase; PKR, pro-
tein kinase R; RA, rheumatoid arthritis; TNF-α, tumor necrosis factor-alpha; TV,
total tissue volume.
primary risk factors for OA development and progression (1, 2).
Several studies have implicated the stress-activated protein kinase
R (PKR) and protein kinase-like endoplasmic reticulum kinase
(PERK) signaling pathways in the pathogenesis of arthritic dis-
ease (3–9). PKR is constitutively expressed in all cells, with levels
increasing upon cellular stress [reviewed in Ref. (10)]. In chondro-
cytes, constitutive PKR expression is known to be high (8), with
further activation (phosphorylation) resulting from cellular stress
leading to up-regulation of matrix degrading enzymes (3, 8), pro-
teoglycan degradation (3, 4), phosphorylation of eukaryotic initi-
ation factor 2 alpha (eIF2α) (11) and down-regulation of protein
synthesis [reviewed in Ref. (10)]. Furthermore, the PKR pathway
is mechano-responsive, gene expression being up-regulated (12)
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at the onset of load-induced OA (13) and mediating translational
arrest induced by cyclic mechanical load in articular cartilage (14).
The cellular level of PKR increases as tissues age, concomitant
with a decrease in the rate of protein synthesis (15), implicat-
ing PKR in the pathogenesis of age-related diseases such as OA.
PERK (16) and PKR (17, 18) are also phosphorylated during
endoplasmic reticulum (ER) stress, leading to eIF2α phosphoryla-
tion and down-regulation of protein synthesis, thus, reducing the
load of protein passing through the ER. Cells that have a high-
secretory capacity, including pancreatic β cells, chondrocytes, and
osteoblasts, are hyper-sensitive to ER stress induction (19–21).
P58IPK (58 kDa inhibitor protein kinase), is a member of the
heat shock protein 40 family and has several known interacting
partners allowing it to have diverse functions in the cell; it is local-
ized to the cytosol where it acts as a cellular inhibitor of PKR and
PERK activity and thus regulator of global protein synthesis and
translocates to the ER during ER stress whereby it acts as a chap-
erone in the ER lumen. It is ubiquitously expressed, abundant in
secretory cells of the pancreas and liver (15, 22), shows increased
expression with age (15) and plays important roles in maintaining
cellular homeostasis (23–27). In its protective role as a molecular
chaperone, it interacts with unfolded proteins such as luciferase,
rhodanese, and insulin to prevent their aggregation (28) and binds
BiP to facilitate misfolded protein folding (29, 30). In addition, it
has also been shown to bind to the ER protein translocation chan-
nel Sec61 to play a role in ER protein degradation (31). P58IPK
mRNA and protein levels are increased in response to ER stress to
inhibit PERK and PKR activity and restore homeostasis (23, 24,
32). Knockdown of P58IPK using siRNA in HEK-293 and HeLa
cells increased levels of total PKR and phosphorylated PERK, with
subsequent eIF2α phosphorylation, inhibition of protein synthe-
sis and apoptosis (24). Knockdown of P58IPK increased release
of tumor necrosis factor-alpha (TNF-α) in rat retinal cells (27),
phosphorylation of eIF2α and expression of ER stress response
proteins in embryonic stem cells (23). Furthermore, P58IPK-null
cells have heightened basal levels of ER stress (26). P58IPK-null
mice are smaller with lower body weights than heterozygous and
wild-type mice, reduced body fat, hypoinsulinemia, and gradual
onset diabetes (25, 26). However, up until now, skeletal phenotype
has not been assessed in P58IPK-null mice.
Given the role of PERK and PKR in cell signaling events associ-
ated with arthritis, we tested the hypothesis that absence of P58IPK
results in a degenerative joint phenotype in vivo. The aims of this
observational study were to describe a phenotypic characterization
of donated knee joints from a P58IPK knockout mouse colony.
MATERIALS AND METHODS
MATERIALS
All chemicals were obtained from Sigma (Poole, UK) unless
otherwise stated and were of analytical grade.
TISSUE
Human OA
The medial tibial plateau (MTP) was obtained from two ran-
domly selected patients undergoing total knee replacement for
OA (female, 83 and 59 years old). Informed consent was gained
from each donor according to protocols approved by the Research
Ethics Committee for Wales (Ref: 10/MRE0928; Cardiff & Vale
Heath Board R&D approval Ref: 10/OAE/497).
P58IPK-null mice
Hind limbs were obtained from previously generated male P58IPK-
null and age-matched wild-type mouse colonies as described (25)
and approved by the University of Washington Institutional Ani-
mal Care and Use Committee. Two age groups were analyzed:
12–13 and 23–25 months. Mice were 100% C57Bl/6 and had been
maintained on a C57Bl/6 background by alternate generation
backcrossing. All comparisons are between null and wild-types of
12–13 months (four null, and three wild-type) and 23–25 months
mice (five null, four wild-type). Where analyses deviate from this
standard comparison, the numbers of animals used are clearly
stated in the figure legends.
SPECIMEN PREPARATION
Human material
Tissue was fixed (2 days, 10% neutral buffered formalin), decalci-
fied (4°C, 10% EDTA, Fisher Scientific), paraffin embedded, and
coronally sectioned (6µm).
Mouse material
Hind limbs were immediately fixed post-mortem in formalin.
For histology and immunohistochemistry, right knee joints were
decalcified as described in Section “Human Material.” Joints were
fixed at 90° and embedded frontally in paraffin blocks for coronal
sectioning parallel to the tibia. Serial sections (5µm) obtained at
100µm intervals through the joint, were dewaxed and rehydrated
prior to staining with toluidine blue or processing for immuno-
histochemistry. Left knee joints were stored in 70% ethanol prior
to radiological and high-resolution micro-computed tomography
(µCT) analysis.
HISTOLOGICAL SCORING
Human MTP
The human MTPs had been previously stained with toluidine blue
(33) and scored for degenerative changes. Sections were shown
to have cartilage fibrillation, proteoglycan loss, and breach of the
tidemark. Cartilage degradation severity (indicated by increasing
Mankin score) increased toward the outer edge of the MTP (33).
Mouse knees
The medial femoral condyle (MFC), MTP, lateral femoral condyle
(LFC), and lateral tibial plateau (LTP) from two sections (either
side of the center of the joint, approximately 200µm apart) were
scored for degenerative changes by two independent observers
blinded to genotype. For each mouse, a single score representing
the mean value from both observers and sections was used for
statistical comparisons. The osteoarthritis research society inter-
national (OARSI) scoring method (34) was used with toluidine
blue staining utilized instead of safranin O. The OARSI system
uses a 0–6 subjective score for osteoarthritic changes (Table S1 in
Supplementary Material: parameter 1), 0–3 for subchondral bone
changes (Table S1 in Supplementary Material: parameter 2), and
0–5 for proteoglycan depletion (Table S1 in Supplementary Mate-
rial: parameter 3). This gives a total score of 14 for each quadrant
(parameters 1–3).
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RADIOLOGICAL ANALYSIS
A KODAK In vivo Imaging System FX Pro (AMV, Lincoln, UK)
was used to produce high-resolution digital radiographs of medial
and frontal views of the left mouse hind legs. Capture settings
were as follows: 2× binning, 0.4 mm aluminum filter, 30 s expo-
sure, KVP 35, F-stop 3.99, FOV 22.2 mm. A region of interest
(ROI), of the same size and shape, and located as near to the infe-
rior tibio-fibular joint as possible, was defined (see Figure S1 in
Supplementary Material). Placing the ROI as close to this joint as
possible provided us with a landmark allowing us to make direct
comparisons of the same region across animals. The exact loca-
tion was defined from the Chi-square value, derived from the bone
density analysis, which is a measure of the fitting quality in the
non-linear least-squares fit of the cylinder to the bone segment.
The ROI was analyzed for changes in long-bone density (g/cm3)
using Carestream Molecular Imaging Software (version 5.3.3) with
bone density software module (35). In addition, a ROI was drawn
around any calcification within the Achilles to measure its area
(pixels) and a linear ROI used to measure the height and width
of the tibia at the tibio-fibular joint (millimeter) (Figure S1 in
Supplementary Material).
HIGH-RESOLUTION µCT ANALYSIS
Left mouse knees were imaged using the SkyScan 1172 (Bruker,
Kontich, Belgium) with a voxel size of 4.8µm (110 mm3) using
previously reported scanning and reconstruction methods (36).
The ROI incorporated 25 lines (0.25 mm) starting from the cen-
tral line of the epiphyses and moving proximally for the femur and
distally for the tibia. We evaluated the effect of genotype and age on
epiphyseal total volume inside the periosteal envelope (TV), bone
volume (BV), medullary volume (MV), and bone volume fraction
(BV/TV) according to ASBMR guidelines (37). Femoral and tib-
ial epiphyseal height, excluding the growth plate, is also reported
(Figure S1 in Supplementary Material) and 3D reconstructions
generated.
IMMUNOHISTOCHEMISTRY
Active PERK and PKR and their endogenous inhibitor were
immunolocalized in sequential sections from two human MTP
using antibodies to phosphorylated PERK (Santa Cruz: sc-32577;
1:50), phosphorylated PKR (Santa Cruz: sc-101783; 1:50), and
P58IPK (Abcam: ac70840; 1:20). Sections were deparaffinized and
rehydrated prior to antigen retrieval (1 mg/mL trypsin for 1 h at
37°C). Each subsequent step was performed at room tempera-
ture unless stated otherwise and between each incubation step,
sections were washed 3 min× 5 min in 0.01 M phosphate buffered
saline (PBS, pH 7.4) containing 0.001% (v/v) Tween 20 (wash
buffer). All antibodies were diluted in wash buffer. Endogenous
peroxidase activity was blocked with 0.3% (v/v) hydrogen peroxide
for 30 min. Sections were subsequently treated with 10% normal
goat serum for 1 h prior to overnight incubation (4°C) with pri-
mary antibody. Biotinylated secondary antibody was applied and
incubated for 30 min detection (Vectastain Elite ABC kit, nickel
enhanced diaminobenzidine, Vector Laboratories). Sections were
finally dehydrated, cleared in xylene, and mounted. Slides were
viewed on a Leica DMRB microscope. IgG controls were negative
(Figure S2 in Supplementary Material).
DATA ANALYSIS
For all statistics, unless stated otherwise, hindlimb characteristics
were compared between null and wild-type mice of 12–13 months
(four null, and three wild-type) and 23–25 months mice (five
null, four wild-type). To assess and compare sample distributions,
graphs show box and whisker plots of minimum and maximum
values, 25th and 75th quartiles and median; outliers revealed by
these plots were removed prior to further analysis. Data were tested
for normality and equal variances prior to analysis (Minitab 16).
Data were analyzed by general linear model analysis of variance
(GLM ANOVA) with two factors (age and genotype) followed by
Tukey’s post hoc test. Differences were considered significant at
p≤ 0.05.
RESULTS
P58IPK-NULL MICE HAVE NARROWER TIBIAS AND SHORTER EPIPHYSES
P58IPK-null mice exhibit a small body phenotype (Figure S3 in
Supplementary Material) (25). Since no previous analysis of the
long bones has been performed, we measured tibial length, width,
and density, as well as height of the epiphyses. Loss of P58IPK
appeared not to affect the overall length of the tibia (Figure 1A;
p= 0.886). However, P58IPK-null mice had significantly shorter
tibial (p= 0.0004) and femoral epiphyses (p= 0.0214) compared
to wild-type mice (Figures 1B,C). This difference occurred in the
tibial epiphyses of both 12–13-month-old (p= 0.032) and 23–25-
month (p= 0.016) old null mice compared to the age-matched
wild-types. In addition, null mice exhibited a significant reduction
in the width of their tibiae at the tibia/fibula intersect when com-
pared to wild-type mice (p= 0.0031; Figure 1D). There appeared
to be no difference in the densities of the long-bone situated
close to the inferior tibio-fibular joint of wild-type and null mice
(Figure 1E).
LOSS OF P58IPK CAUSES JOINT DEGENERATION
Joint degeneration was observed in both P58IPK-null (Figure 2A)
and wild-type (Figure 2B) mice of both ages. These degenera-
tive changes included cartilage tears (red arrows), subchondral
bone changes (yellow arrows), and osteophyte formation (green
arrows). To assess whether loss of P58IPK resulted in joint degener-
ation over and above that expected in aging C57Bl/6 mice (38–41),
knees were scored using an adaptation of the OARSI system
(34). Despite the presence of degeneration in both groups, GLM
ANOVA of OARSI scores revealed that 12–13-month-old null mice
had fourfold higher total scores (sum of all three parameters; Table
S1 in Supplementary Material) in the MFC compartment than
their wild-type, age-matched controls (Figure 2C; p= 0.035 fol-
lowing rank transformation of data). Analysis of individual para-
meters revealed that there was a weak, but inconclusive increase in
the MFC bone score in null mice (parameter 2) (Figure 2D; GLM
ANOVA genotype p= 0.051 following log transformation of data)
and that 12–13-month-old null mice had 6.7-fold higher bone
scores (parameter 2) than age-matched wild-types (Figure 2D;
p= 0.024 following log transformation of data). P58IPK-null mice
had 1.5-fold lower total scores (sum of all three parameters; Table
S1 in Supplementary Material) in the LTP compared to wild-type
mice, but this difference was not significant (Figure 2E; GLM
ANOVA genotype p= 0.086). However, OA scores (parameter 1)
www.frontiersin.org October 2014 | Volume 5 | Article 174 | 3
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gilbert et al. Joint degeneration in P58IPK-null mice
FIGURE 1 |Tibial widths and epiphyseal heights are reduced in
P58IPK-null mice. Radiographs and high-resolution µCT of the left limb from
wild-type and null mice were used to measure tibial lengths (A), tibial
epiphyseal heights (B), femoral lengths (C), and tibiae widths at the
tibia/fibula intersect (D). Tibial bone density was measured close to the
inferior tibio-fibular joint of wild-type and null mice [(E), Figure S1 in
Supplementary Material]. Significant differences were detected by GLM
ANOVA and Tukey’s post hoc test: *p≤0.05; **p<0.01; ***p<0.001. For
tibial length, width, and bone density measurements: 12–13-month-old mice
n=4 null, n=3 wild-type and 23–25-month-old mice n=5 null, n=4
wild-type. For micro CT measurements: 12–13-month-old mice n=3 null,
n=3 wild-type and 23–25-month-old mice n=5 null, n= 4 wild-type.
were significantly reduced in the LTP (Figure 2F; GLM ANOVA
genotype p= 0.033 following log transformation of data).
High-resolution µCT analysis revealed a significant reduction
in bone mass in P58IPK-null mice (Table 1). GLM ANOVA revealed
a significant effect of genotype on tibial bone with loss of P58IPK
reducing TV (p= 0.002), BV (p< 0.0001), and BV/TV (p= 0.01).
BV in 23–25-month-old null mice was significantly reduced com-
pared to age-matched wild-types (p= 0.03). IndividualµCT slices
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FIGURE 2 | Knee joint degeneration is increased in P58IPK-null mice.
(Continued)
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FIGURE 2 | Continued
Examples of toluidine blue stained coronal sections from the MTPs from
P58IPK-null (A) and wild-type (B) mice from both age groups (12–13 months:
top panels; 23–25 months: bottom panels) are shown representing typical
signs of joint degeneration: cartilage tears and degeneration (red arrows);
subchondral bone changes (yellow arrows); and osteophyte formation (green
arrows). Scale bars=500µm. The OARSI scoring method (Table S1 in
Supplementary Material) was used to determine whether null mice had
degeneration over and above that commonly observed in C57Bl/6 wild-type
mice. Total scores [parameters 1–3; (C)] and bone scores [parameter 2;
(D)] from the MFC and total scores [parameters 1–3; (E)] and OA scores
[parameter 1; (F)] from the LTP obtained using are shown. Significant
differences were detected by GLM ANOVA and Tukey’s post hoc test:
*p≤0.05. LTP, lateral tibial plateau; MFC, medial femoral condyle. OARSI
scores: 12–13-month-old mice n=3 null, n=3 wild-type and
23–25-month-old mice n=4 null, n=4 wild-type.
Table 1 | Bone parameters measured using high-resolution µCT.
P58IPK-null Wild-type
Tibia Femur Tibia Femur
TV (mm3)
12–13 months 0.404± 0.014
0.397± 0.013
}
**
0.416± 0.010
0.394± 0.014a
}
*
0.472±0.024 0.437±0.031
23–25 months 0.450±0.013 0.484±0.022
BV (mm3)
12–13 months 0.231± 0.012
0.175± 0.009a
}
***
0.194± 0.008
0.150± 0.008b
}
***
0.276±0.007 0.224±0.019
23–25 months 0.248±0.029 0.239±0.016
BV/TV (%)
12–13 months 57.37± 2.84
44.17± 2.21
}
*
46.70± 2.75
37.95± 1.39a
}
**
58.59±2.21 51.10±1.51
23–25 months 55.52±7.12 49.47±3.87
MV (mm3)
12–13 months 0.172±0.013 0.222±0.017 0.197±0.020 0.213±0.014
23–25 months 0.222±0.013 0.244±0.010 0.201±0.034 0.245±0.025
Bone parameters obtained from µCT analysis of a ROI incorporating 25 lines (0.25 mm) starting from the central line of the epiphyses and moving proximally for the
femur and distally for the tibia.
TV, total volume within the periosteal envelope; BV, bone volume; BV/TV, bone volume fraction; MV, marrow volume.
Data represented as mean±SEM (n=3–5). Significant differences were detected by GLM ANOVA andTukey’s post hoc test. Genotype effects are shown *p<0.05;
**p<0.01; ***p<0.001 compared to the same compartment in wild-type mice.
Age effects are shown ap<0.05; bp<0.01 compared to the same compartment in age-matched wild-type mice.
revealed that bone loss was largely confined to the medial plateau
of the tibiae (Figure 3).
General linear model analysis of variance also revealed a sig-
nificant effect of genotype on the femoral bone with loss of
P58IPK reducing TV (p= 0.013), BV (p= 0.0005), and BV/TV
(p= 0.007). Femora from 23 to 25-month-old mice were smaller
than those from age-matched wild-type mice with 18% reduction
in TV (bone volume+marrow volume;p= 0.023),37% reduction
in BV (p= 0.0012), and a significant overall reduction of femoral
BV fraction (BV/TV; p= 0.025). Individual slices reveal that bone
loss occurred across the femoral condyle (Figure 3).
A SEVERE DEGENERATIVE PHENOTYPE OCCURS IN A SUBSET OF
P58IPK-NULL MICE
A very severe degenerative phenotype, not seen in any of the seven
wild-type mice, was observed in a third of null mice; one from
the 12–13 month group (Figures 4A–E) and two from the 23–25
month group (Figures 4F–O). The degeneration included loss of
cartilage with erosion through to the subchondral bone, abnormal
bone changes, and large osteophytes within the medial side of the
joint. Moderate cartilage erosion was also observed in the lateral
joint compartment of these mice. Heterotopic chondro-osseous
tissue formed within the medial joint of each of the three mice with
severe degeneration (Figures 4B,G,L), which was not observed in
any other mice. Ectopic bone within the medial collateral liga-
ments and the joint capsule was observed within the contra-lateral
leg of two of these mice (Figures 4C,M). High-resolution µCT
images revealed changes in joint shape and osteophyte forma-
tion on the tibiae (Figures 4D,I,N) and femurs (Figures 4E,J,O)
of these mice with severe degeneration. The extensive ectopic
bone formation was further evident in frontal and side view
3D reconstructions from the µCT scans (Figure S4 in Supple-
mentary Material). In addition to the two age groups included
in this study, we also examined four 18-month-old mice (wild-
type n= 2; null n= 2) and found that this severe phenotype was
observed in one of the null mice (Figure S5 in Supplementary
Material).
P58IPK-NULL MICE HAVE LESS CALCIFICATION IN THEIR ACHILLES
TENDON
Achilles tendon calcification occurred in 95% of all mice
(Figure 5A), with P58IPK-null mice exhibiting significantly less
calcification than wild-types (p= 0.002, Figure 5B). There was
an age-related increase in Achilles calcification in wild-type
mice (3.3-fold increase in 23–25-month-old mice compared
to 12–13-month-old mice, p= 0.0023). Null mice showed a
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FIGURE 3 | Significant bone loss occurs in the knees of P58IPK-null
mice. MicroCT analysis of a ROI incorporating 25 lines (0.25 mm) starting
from the central line of the epiphyses and moving proximally for the femur
and distally for the tibia were obtained. Representative images are shown
of slices taken from the top, middle and bottom of the 25 lines. (A) images
from 12 to 13-month-old mice; (B) images from 23 to 25-month-old mice.
In each slice, the lateral compartment is at the top and medial at the
bottom.
threefold reduction in calcified tissue at 23–25 months compared
to age-matched wild-types (p= 0.0009).
EXPRESSION LEVELS OF PHOSPHORYLATED PKR AND PERK IN HUMAN
OA JOINT TISSUES CORRELATE TO THE SEVERITY OF DEGENERATION
Sections from two human MTPs, with moderate to extensive OA
degeneration (33), were examined for evidence of active stress
signaling and representative images shown (Figure 6; Figure
S6 in Supplementary Material). Toluidine blue stained sections
show that both patients had more degeneration toward the
outer edge of the plateau (Figures 6A,D). Patient 1 had exten-
sive cartilage loss down to the subchondral bone and severe
damage in what remained of the cartilage (Figure 6A). Patient
2 showed signs of proteoglycan loss, cartilage fibrillation, and
a small region of significant cartilage fibrillation (Figure 6D).
Immunohistochemistry revealed that active PERK and PKR were
present in a range of joint tissues regardless of degenerative state
(described in Figure S6 in Supplementary Material). However,
in patient 1 (Figure 6A), more extensive staining was observed
in the cartilage that was more severely damaged and, in par-
ticular, in the bone in regions underlying significant cartilage
loss (Figures 6B,C). In patient 2 (Figure 6B), the staining for
active PERK and PKR was more apparent in the cartilage as the
damage increased in severity toward the outer edge but the exten-
sive bone changes were not observed (Figures 6E,F). Staining
for P58IPK was very limited throughout with very low or neg-
ative staining in osteocytes, bone lining cells, and chondrocytes
(Figure S6 in Supplementary Material). However, positive staining
was observed in the bone marrow (Figure S6O in Supplementary
Material).
DISCUSSION
The aims of this observational study were to describe a phenotypic
characterization of donated knee joints from a P58IPK knockout
mouse colony. This study demonstrates for the first time that
knockout of P58IPK, the cellular inhibitor of PKR and PERK, alters
bone size and volume, and leads to a degenerative joint pheno-
type. Epiphyseal height was significantly reduced in the femora
and tibiae of null mice, which also displayed significantly nar-
rower tibiae than those of wild-type mice. These effects may be
due to the reduced body fat and reduced body weight phenotype
of P58IPK-null mice (25) (Figure S3 in Supplementary Material),
either reducing load on the bones or reflecting direct effects of
hypoinsulinemia and diabetes (25, 26) on bone growth.
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FIGURE 4 | A subset of P58IPK-null mice reveal a severe degenerative
joint phenotype. Coronal sections, stained with toluidine blue, are
depicted from the right knee joints of three of the P58IPK-null mice aged
12–13 months (A) and 23–25 months (F,K) old with the severe
phenotype. Significant bone remodeling and cartilage loss can be seen in
the MTP and MFC. Magnified views of the heterotopic chondro-osseous
tissue observed in the medial capsule of these sections (box) are
depicted (B,G,L) showing areas of bone marrow formation (yellow
arrows) along with osteophyte formation (red circles) in two of the mice.
Coronal radiographs from the contra-lateral legs of each animal depicted
in (A,F,K) are shown (C,H,M) highlighting the ectopic radio-dense areas
in the medial collateral ligaments and the joint capsule of two of these
mice [(C,M); yellow triangles]. High-resolution µCT images of the
contra-lateral leg revealed changes in joint shape and osteophyte
formation on the tibiae (D,I,N) and femurs (E,J,O). Scale bar= 500µm
except for (A,F,K)= 1 mm.
These data also show that P58IPK plays a critical role in main-
taining joint integrity. It has been well documented that C57Bl/6
mice develop spontaneous OA-like lesions as they age (38–41)
and indeed this was observed in the wild-type mice used within
this study. However, loss of P58IPK caused significantly increased
joint degeneration scores that were greater than those which occur
spontaneously in the aging wild-type C57Bl/6 mice. Furthermore,
joint degeneration in P58IPK-null mice localized to the medial
femoral compartment whereas C57Bl/6 mice develop spontaneous
OA-like lesions predominantly in the lateral side of the tibia-
femoral joint as they age (39, 40). The lateral compartment of
P58IPK-null mice appeared relatively protected from age-related
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FIGURE 5 | Achilles tendon calcification is reduced in P58IPK-null mice.
(A) Radiographs from the left leg of wild-type and null mice show areas of
calcification within the Achillles tendon (yellow arrow). A ROI was drawn
around the calcified tissue and bone density software used to measure the
area of calcification (B) with significant differences detected by GLM ANOVA
and Tukey’s post hoc test: **p< 0.01; ***p<0.001. Achilles calcification area:
12–13-month-old mice n=5 null, n=3 wild-type and 23–25-month-old mice
n=5 null, n=4 wild-type.
joint damage observed in wild-type mice, which may reflect a
shift of loading from lateral to medial compartments in null mice.
Such altered joint biomechanics is consistent with the increased
subchondral bone OARSI scores in 12–13-month-old null mice,
which were much greater in the medial and less in the lateral
compartments, when compared to wild-types. A major risk factor
for OA is abnormal loading and factors such as increased loading
through the medial side of the joint (42) and altered contact surface
areas on femoral condyles versus tibial plateau, mean that load-
induced changes vary across different regions of the joint (43).
There is some evidence that specific mechanical loading regimes
can activate PKR in articular cartilage (14), although this has not
been tested in bone.
High-resolution µCT analysis revealed significant bone loss
from the region beneath the subchondral plate in the MTP and
across the entire femoral condyle of mice lacking P58IPK. This
may reflect osteoblast insufficiency, enhanced resorption (44) or
a combination of these, associated with the diabetic phenotype
of these null mice (45, 46). Both PERK and PKR are implicated
in bone cell signaling. PERK plays a crucial role in bone devel-
opment, osteoblast differentiation and maturation (47) whereas
inactivation of PKR reduces osteoblast differentiation and cal-
cification (48–50) and osteoclast differentiation (51). Thus, the
changes in the subchondral bone and loss of bone below the sub-
chondral plate in P58IPK-null mice may reflect site-specific effects
of over-activated PERK and/or PKR on bone remodeling.
A severe phenotype, characterized by complete loss of the artic-
ular cartilage from the medial tibial and femoral compartments,
subchondral bone remodeling, osteophyte formation and calci-
fication of the collateral ligaments, was observed in a third of
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FIGURE 6 | Expression of phosphorylated PKR and PERK correlate with the degree of degeneration in human OA tissue.
(Continued)
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FIGURE 6 | Continued
Sections from the MTP of two patients undergoing total knee
replacement for OA were stained with toluidine blue to establish the
degree of tissue degeneration. The subcellular localization of
phosphorylated PKR and PERK were determined by
immunohistochemistry. Patient 1 had complete cartilage loss and severe
bone changes toward the outer edge of the plateau with the remaining
cartilage showing signs of significant fibrillation and proteoglycan loss
(A). Five regions (black boxes; i–v) highlight areas of limited damage (joint
middle) to severe damage (outer edge). Representative staining for
phosphorylated PERK (B) and PKR (C) from these five regions are shown
revealing more staining in the cartilage as the damage progresses
outwards and significant activation in the remodeling bone in the areas
underlying the complete loss of cartilage. Patient 2 had cartilage
fibrillations and proteoglycan loss, which were more extensive toward the
outer edge but the damage was less extensive that patient 1 (D). Four
regions (black boxes; i–iv) highlight areas of limited damage (joint middle)
to severe damage (outer edge). Representative staining for
phosphorylated PERK (E) and PKR (F) from these four regions are shown
revealing more staining in the cartilage as the damage progresses
outwards but not the extensive activity in the bone as observed for
patient 1. Scale bars=100µm.
P58IPK-null mice. The reason for this variability is unknown but
may reflect individual variations in immune status, ER stress, or
joint loading. For example, virally infected P58IPK-null mice show
enhanced inflammatory responses (26), and cells with a high-
secretory burden from P58IPK-null mice have reduced capacity
to cope with ER stress (31). In addition, ossification of collat-
eral ligaments, as observed in all P58IPK-null mice with severely
damaged joints, may cause, or be a consequence of altered joint
loading. Such ossification occurs in the Dunkin–Hartley guinea
pig (52) and STR/ort mouse models of spontaneous knee OA (53,
54), where ossification of the collateral and patellar ligaments and
Achilles tendon is thought to alter the mechanical stability of the
knee, contributing to cartilage breakdown and OA (55, 56). Tran-
section of the anterior cruciate ligament (ACL) or non-invasive
ACL rupture in mice also alters joint biomechanics and results in
a remarkably similar severe phenotype to that observed in P58IPK-
null mice with ectopic bone formation within the joint capsule,
significant cartilage erosion and bone sclerosis (57–59). Of note,
bone and proteoglycan deposition in the collateral ligaments, sig-
nificant cartilage erosion on the femur and tibia and sclerosis in the
underlying bone have also been observed in aging IL-6 knockout
(60) and GM3 synthase knockout mice (61). Interestingly, absence
of GM3 synathase prevents the conversion of GM3 to gangliosides,
which are required to suppress MMP-13 and ADMATS-5 produc-
tion. Whether PKR and/or PERK signaling pathways play a role in
these models remains to be determined.
Although calcification of the periarticular structures only
occurred in P58IPK-null mice with the severe phenotype, knee
degeneration occurred in all P58IPK-null mice, suggesting that
calcification is not the initiating factor in these mice. There is no
doubt, however, that the calcified/ossified tissue will change the
stiffness of the periarticular structures, alter joint biomechanics
and accelerate degeneration. Calcification of the Achilles tendon
increased with age in wild-type mice as expected (62), but inter-
estingly, older P58IPK-null mice had significantly less calcification
than age-matched wild-types. This may reflect the reduced body
weight of these animals or abnormal biomechanics in the knee
altering loading through the Achilles.
Loss of P58IPK increases levels of phosphorylated PERK and
PKR (24). PERK and ER stress have been implicated in the
pathogenesis of OA (5–7) and activation of PKR causes cartilage
breakdown (3, 4, 63), is linked to load-induced OA (12) and is
mechano-responsive (14). Consistent with this, and to our knowl-
edge, for the first time, we demonstrate that active PKR and PERK
are both expressed at the same time in a range of joint cells in
human osteoarthritic tissue. Most notable is that the levels of these
kinases appear to correlate with the degree of cartilage damage and
that the highest expression is observed within the bone in areas
underlying severe cartilage loss. In addition, there appears to be
some evidence for region-specific activation of PKR and PERK in
human OA, with PERK in surface zone cartilage cells and PKR in
the mid zone. These observations are consistent with the notion
that over-activation of the PKR pathway in P58IPK-null mice com-
bined with increased loading of the medial compartment, may
contribute to joint degeneration.
Given the functional cross-talk between PERK and PKR (64)
and without the control of P58IPK, the extent of activation of
these pathways may be exaggerated in these knockout mice. Stress,
viral infection, and/or altered joint biomechanics in individual
mice may increase inflammatory responses, heighten ER stress,
and induce load related responses to cause the severe degenerative
joint phenotype as seen in a cohort of these mice. In future stud-
ies, it would be advantageous to “challenge” younger P58IPK-null
animals with an inflammatory or mechanical insult prior to the
onset of overt degeneration to determine whether this initiates the
severe degenerative joint phenotype. However, the only material
currently available for skeletal analysis of P58IPK knockout mice is
that from the hind limbs we describe in this paper. To our knowl-
edge, there are no living colonies of this knockout animal and no
frozen embryos available worldwide. Given the limited material
available, our study does possess some limitations, namely, the
lack of correlation of morphological changes directly with over-
activation of the PKR/PERK pathway, the inability to determine
the extent of ER stress, the effect of the loss of function of P58IPK
on its role as a co-chaperone, and the relatively small sample size
in each age group. That said this does not detract from the strong
degenerative joint phenotype we have observed in these null ani-
mals providing the first in vivo evidence showing a critical role for
P58IPK in OA-like joint degeneration. The major changes observed
in P58IPK knockout bone is of particular interest in defining an
important role for these pathways in degenerative joint disease.
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